C. Fermé

发表

[Non-Hodgkin lymphoma arising in a case of Waldmann's intestinal lymphangiectasis].

P. Hérait, C. Gisselbrecht, C. Fermé, 1985, Nouvelle revue francaise d'hematologie.

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.

J. Rossi, G. Salles, R. Bouabdallah, 2008, Blood.

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

Andrew Lister, Anne Sonet, Hervé Tilly, 2011, The Lancet.

Updated 6 Year Follow-Up Of The PRIMA Study Confirms The Benefit Of 2-Year Rituximab Maintenance In Follicular Lymphoma Patients Responding To Frontline Immunochemotherapy

A. Hagenbeek, G. Salles, A. López-Guillermo, 2013 .

Extranodal Hodgkin disease: spectrum of disease.

C. Fermé, V. Meignin, C. Hennequin, 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients

C. Fermé, C. Soussain, D. Decaudin, 2008, Anti-cancer drugs.

nine cases and review of the literature

C. Gisselbrecht, C. Fermé, J. Trédaniel, 2002 .

Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.

C. Gisselbrecht, C. Fermé, M. Marty, 1993, International journal of radiation oncology, biology, physics.

Randomized Phase III Study Comparing an Early PET Driven Treatment De-Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study

G. Salles, R. Bouabdallah, A. Stamatoullas, 2015 .

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

J. Raemaekers, R. Bouabdallah, A. Stamatoullas, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas.

C. Fermé, S. Koscielny, V. Ribrag, 2005, International journal of radiation oncology, biology, physics.

Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma.

B. Coiffier, H. Tilly, C. Gisselbrecht, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Benefit of rituximab combined to ACVBP (R-ACVBP) over ACVBP in 209 poor- risk BDLC NHL patients treated with up-front consolidative autotransplantation: A GELA phase II trial (LNH 2003-3).

B. Coiffier, O. Casasnovas, P. Feugier, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of oxaliplatin in patients with advanced cancer

M. Espié, C. Fermé, M. Marty, 2004, Cancer Chemotherapy and Pharmacology.

Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins’s disease or non-Hodgkin’s lymphoma

C. Gisselbrecht, C. Fermé, C. Hennequin, 1999, Bone Marrow Transplantation.